SyFungin (Syntrion GmbH)
Welcome to the PulseAid listing for the SyFungin drug offered from Syntrion GmbH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Syntrion GmbH |
| NON-PROPRIETARY NAME: | CANDIDA PARAPSILOSIS |
| SUBSTANCE NAME: | CANDIDA PARAPSILOSIS |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2014-10-15 |
| END MARKETING DATE: | 2019-09-30 |
SyFungin HUMAN OTC DRUG Details:
| Item Description | SyFungin from Syntrion GmbH |
| LABELER NAME: | Syntrion GmbH |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2014-10-15 |
| END MARKETING DATE: | 2019-09-30 |
| PRODUCT ID: | 10424-105_20fab166-f103-4749-94a5-e3e909ac2ed8 |
| PRODUCT NDC: | 10424-105 |
| APPLICATION NUMBER: | |
Other CANDIDA PARAPSILOSIS Pharmaceutical Manufacturers / Labelers:
